- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06239857
Epidural Pulsed Radiofrequency Treatment in Failed Back Surgery Syndrome
Evaluation of the Effect of Epidural Pulsed Radiofrequency Treatment on Pain in Patients Diagnosed With Failed Back Surgery Syndrome (Persistant Spinal Pain Syndrome)
Low back pain can persist in some patients with history of back surgery. In some cases, an increase in pain may even occur, and chronic pain may make treatment more difficult. A component of chronic pain is neuropathic pain, and its specific evaluation and treatment is important. Low back pain and radicular pain in the lower extremities are the main symptoms of failed back surgery syndrome (also called persistent spinal pain syndrome in new terminology).
There are many methods for treatment of failed back surgery syndrome, such as analgesic medications, physical therapy, interventional pain treatment applications, and re-surgery options. Epidural pulsed radiofrequency therapy has recently become popular among interventional pain management procedures, and studies on its effectiveness are increasing. However, studies with a multifaceted approach that also evaluate neuropathic pain are lacking in the literature. In this study, it was planned to investigate the effect of epidural pulsed radiofrequency therapy on pain palliation, including neuropathic pain, in patients diagnosed with failed back surgery syndrome.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Burak Erken, MD
- Phone Number: +902129096000
- Email: burak_erken@hotmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being between the ages of 18-80
- History of at least one operation due to lumbar disc herniation
- Having radicular pain radiating to the lower extremities
Exclusion Criteria:
- Having undergone surgery for an etiology other than lumbar disc herniation
- Accompanying spinal stenosis and spondylolisthesis
- Presence of fracture, infection, coagulopathy and pregnancy
- Mental disorders that may negatively affect cooperation during assessments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Epidural pulsed radiofrequency treatment
All patients diagnosed with failed back surgery syndrome will receive epidural pulsed radiofrequency treatment.
|
The radiofrequency treatment is applied under sterile conditions in the operating room environment.
The target epidural area is reached under fluoroscopy guidance using a radiofrequency needle.
After control of the needle position, radiofrequency treatment is given.
Radiofrequency parameters are set as maximum temperature 42 degrees, 45 volts, duration 6 minutes, pulse rate 2 hertz and pulse width 20 milliseconds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pain severity score
Time Frame: A single point in time (pre-procedural time)
|
Pain severity is evaluated by using Numerical Rating Scale (NRS).
In evaluation, the patient scores the pain intensity between 0 (no pain) and 10 (worst pain).
It is easy to apply and takes a short time.
|
A single point in time (pre-procedural time)
|
|
Change in pain severity score
Time Frame: A single point in time (post-procedural 1.month)
|
Pain severity is evaluated by using Numerical Rating Scale (NRS).
In evaluation, the patient scores the pain intensity between 0 (no pain) and 10 (worst pain).
It is easy to apply and takes a short time.
|
A single point in time (post-procedural 1.month)
|
|
Change in pain severity score
Time Frame: A single point in time (post-procedural 3.month)
|
Pain severity is evaluated by using Numerical Rating Scale (NRS).
In evaluation, the patient scores the pain intensity between 0 (no pain) and 10 (worst pain).
It is easy to apply and takes a short time.
|
A single point in time (post-procedural 3.month)
|
|
Change in pain severity score
Time Frame: A single point in time (post-procedural 6.month)
|
Pain severity is evaluated by using Numerical Rating Scale (NRS).
In evaluation, the patient scores the pain intensity between 0 (no pain) and 10 (worst pain).
It is easy to apply and takes a short time.
|
A single point in time (post-procedural 6.month)
|
|
Change in pain severity score
Time Frame: A single point in time (post-procedural 12.month)
|
Pain severity is evaluated by using Numerical Rating Scale (NRS).
In evaluation, the patient scores the pain intensity between 0 (no pain) and 10 (worst pain).
It is easy to apply and takes a short time.
|
A single point in time (post-procedural 12.month)
|
|
Change in the number of patients with neuropathic pain
Time Frame: A single point in time (pre-procedural time)
|
The presence of neuropathic pain is assessed by Doleur Neuropathique-4 (DN-4) Questionnaire.
It consists of two parts, including a physician examination part and a neuropathic pain related findings part in which the patients are questioned.
A score above 4 indicates the presence of neuropathic pain.
|
A single point in time (pre-procedural time)
|
|
Change in the number of patients with neuropathic pain
Time Frame: A single point in time (post-procedural 1.month)
|
The presence of neuropathic pain is assessed by Doleur Neuropathique-4 (DN-4) Questionnaire.
It consists of two parts, including a physician examination part and a neuropathic pain related findings part in which the patients are questioned.
A score above 4 indicates the presence of neuropathic pain.
|
A single point in time (post-procedural 1.month)
|
|
Change in the number of patients with neuropathic pain
Time Frame: A single point in time (post-procedural 3.month)
|
The presence of neuropathic pain is assessed by Doleur Neuropathique-4 (DN-4) Questionnaire.
It consists of two parts, including a physician examination part and a neuropathic pain related findings part in which the patients are questioned.
A score above 4 indicates the presence of neuropathic pain.
|
A single point in time (post-procedural 3.month)
|
|
Change in the number of patients with neuropathic pain
Time Frame: A single point in time (post-procedural 6.month)
|
The presence of neuropathic pain is assessed by Doleur Neuropathique-4 (DN-4) Questionnaire.
It consists of two parts, including a physician examination part and a neuropathic pain related findings part in which the patients are questioned.
A score above 4 indicates the presence of neuropathic pain.
|
A single point in time (post-procedural 6.month)
|
|
Change in the number of patients with neuropathic pain
Time Frame: A single point in time (post-procedural 12.month)
|
The presence of neuropathic pain is assessed by Doleur Neuropathique-4 (DN-4) Questionnaire.
It consists of two parts, including a physician examination part and a neuropathic pain related findings part in which the patients are questioned.
A score above 4 indicates the presence of neuropathic pain.
|
A single point in time (post-procedural 12.month)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Günay Yolcu, MD, Basaksehir Cam & Sakura Şehir Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 27.12.2023.700
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.